Cargando…
Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
Small-cell lung cancer (SCLC) has a poor prognosis and can be diagnosed with systemic metastases. Nevertheless, the molecular mechanisms underlying the development of SCLC are unclear, requiring further investigation. The current research aims to identify relevant biomarkers and available drugs to t...
Autores principales: | Li, Yi, Zhou, Xiwen, Lyu, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560035/ https://www.ncbi.nlm.nih.gov/pubmed/37808164 http://dx.doi.org/10.1515/med-2023-0806 |
Ejemplares similares
-
Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment
por: Zhou, Jiao, et al.
Publicado: (2023) -
Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics
por: Wang, Dongjiao, et al.
Publicado: (2022) -
Identification of key genes and pathway related to chemoresistance of small cell lung cancer through an integrative bioinformatics analysis
por: Zeng, Fan-Rui, et al.
Publicado: (2022) -
Identification of hub genes and small molecule therapeutic drugs related to breast cancer with comprehensive bioinformatics analysis
por: Hao, Mingqian, et al.
Publicado: (2020) -
Identification of key genes in non-small cell lung cancer by bioinformatics analysis
por: Zhang, Li, et al.
Publicado: (2019)